TrialThe oncologist2017

Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301.

Eisaku Miyauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.